Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes-Reference-Cited by-同舟云学术

Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes

Published:2020-12 Issue:9 Volume:1 Page:100154
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Carlier Aurélie,Phan Franck^ORCID,Szpigel Anaïs,Hajduch Eric^ORCID,Salem Joe-Elie,Gautheron Jérémie,Le Goff Wilfried^ORCID,Guérin Maryse,Lachkar Floriane^ORCID,Ratziu Vlad,Hartemann Agnès,Ferré Pascal^ORCID,Foufelle Fabienne,Bourron Olivier^ORCID

Funder

Fondation pour la Recherche Médicale

Agence Nationale de la Recherche

Institut National de la Santé et de la Recherche Médicale

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference39 articles.

1. Stress signals for apoptosis: ceramide and c-Jun kinase;Basu;Oncogene,1998

2. Ceramide- and ERK-dependent pathway for the activation of CCAAT/enhancer binding protein by interleukin-1beta in hepatocytes;Giltiay;J. Lipid Res.,2005

3. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis;Teichgräber;Nat. Med.,2008